TrialBMJ open2025

Morphine for chronic breathlessness (MABEL) in the UK: a health economic evaluation of a multisite, parallel-group, dose titration, double-blind, randomised, placebo-controlled trial.

Marek Jan Atter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.